Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy

Clinical Endocrinology

Volumn 51, Issue 4, 1999, Pages 497-502

  Landin Wilhelmsen, Kerstin ^a   Bryman, Inger ^a   Windh, Marianne ^a   Wilhelmsen, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH PROMOTOR; OSTEOCALCIN; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE MINERALIZATION; CONTROLLED STUDY; DISEASE MARKER; ESTROGEN THERAPY; FEMALE; FRACTURE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; TURNER SYNDROME;

ADOLESCENT; ADULT; AGED; BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; BONE DENSITY; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, BONE; GROWTH HORMONE; HEARING DISORDERS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS; PARATHYROID HORMONE; TURNER SYNDROME;

EID: 0032693729     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00841.x     Document Type: Article

References (18)

1. Blanchet, C., Dodin, S., Dumont, M., Giguère, Y., Turcot-Lemay, L., Beauchamp, J. & Prud'homme, D. (1998) Bone mineral density in French Canadian women. Osteoporosis International, 8, 268-273.
2. Davies, M.C., Gulekli, B. & Jacobs, H.S. (1995) Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clinical Endocrinology, 43, 741-746.
3. Gargantini, L., Weber, G., Braggion, F. & Cazzuffi, M.A. (1988) Bone mineral content in Turner's syndrome. Pediatric Research, 23, 127.
4. Ho, K.K. & Weissberger, A.J. (1992) Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. Journal of Bone and Mineral Research, 7, 821-827.
5. Holl, R.W., Kunze, D., Etzrodt, H., Teller, W. & Heinze, E. (1994) Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. European Journal of Pediatrics, 153, 11-16.
6. Isaksson, O.G.P., Lindahl, A., Nilsson, A. & Isgaard, J. (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrine Reviews, 8, 426-438.
7. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G., Rosén, T., Lindstedt, G., Lundberg, P.-A. & Bengtsson, B.-Å. (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology, 41, 351-357.
8. 3 is unaffected. Results from a general population study in Göteborg, Sweden (The WHO MONICA Project). European Journal of Clinical Nutrition, 49, 400-407.
9. Naeraa, R.W., Brixen, K., Hansen, R.M., Hasling, C., Mosekilde, L., Andresen, J.H., Charles, P. & Nielsen, J. (1991) Skeletal size and bone mineral content in Turner's syndrome: Relation to karyotype, estrogen treatment, physical fitness and bone turnover. Calcified Tissue International, 49, 77-83.
10. Neely, K.E., Marcus, R., Rosenfeld, R.G. & Bachrach, L.K. (1993) Turner syndrome adolescents receiving growth hormone are not osteopenic. Journal of Clinical Endocrinology and Metabolism, 76, 861-866.
11. Prentice, A., Parsons, T.J. & Cole, T.J. (1994) Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. American Journal of Clinical Nutrition, 60, 837-842.
12. Ross, J.L., Long, L.M., Feuillan, P., Cassorla, F. & Cutler, G.B. (1991) Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. Journal of Clinical Endocrinology and Metabolism, 73, 355-359.
13. Shore, R.M., Chesney, R.W., Mazess, R.P., Rose, P.G. & Bargman, G.J. (1982) Skeletal demineralization in Turner's syndrome. Calcified Tissue International, 34, 519-522.
14. Smith, M.A., Wilson, J. & Price, W.H. (1982) Bone demineralisation in patients with Turner's syndrome. Journal of Medical Genetics, 19, 100-103.
15. Stephan, J.J., Musilova, J. & Pacorvsky, V. (1989) Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. Journal of Bone and Mineral Research, 4, 193-198.
16. Sylvén, L., Hagenfeldt, K. & Ringertz, H. (1995) Bone mineral density in middle-aged women with Turner's syndrome. European Journal of Endocrinology, 132, 47-52.
17. Westphal, O. (1993) Non-conventional growth hormone treatment in short children. Acta Endocrinology, 128 (Suppl.), 10-11.
18. Wilhelmsen, L., Johansson, S., Rosengren, A., Wallin, I., Dotevall, A. & Lappas, G. (1997) Risk factors for cardiovascular disease during the period 1985-95 in Göteborg, Sweden, The GOT-MONICA Project. Journal of Internal Medicine, 242, 199-211.